Full-Time

Harvest Agent

Posted on 7/15/2025

Cresco Labs

Cresco Labs

1,001-5,000 employees

Cannabis cultivation, processing, and retailing

Compensation Overview

$18/hr

Lincoln, IL, USA

In Person

Category
Lab & Research (2)
,
Requirements
  • Two years of experience in a general production, preferably a regulated field producing for human consumption. Or, any satisfactory combination of experience and training which clearly demonstrates the ability to perform the above-described duties.
  • The ability to remember and adhere to all compliance, quality, departmental and human resource guidelines.
  • The ability to work in a team setting.
  • Strong problem-solving skills.
  • Effective time-management skills and ability to multi-task.
  • Ability to sit and perform bud removal with scissors for extended time periods.
  • Ability to work in a fast-paced, changing, and challenging environment.
  • Requires work around plant material, which could include exposure to plant pollen and/or dust.
  • Requires ability to sit, stand, kneel, and/or do repetitive actions with your hands for long periods of time.
  • Requires ability to lift up to 50 lbs to torso level.
Responsibilities
  • Responsible for harvesting and first stages in processing of Cresco Labs' product while ensuring high quality and visual aesthetic.
  • Monitor and control dry rooms to optimize specific flower qualities and standards.
  • Weigh & package our Fresh/Frozen Flower.
  • Buck, weigh, bag/tag/label the product for ID.
  • Utilize attention to detail to hand select product for the optimal size, quality, and appearance.
  • Perform repetitive tasks for long periods of time – a combination of sitting, standing, moving, and performing vigorous activities in cool and hot temperatures.
  • Strictly adheres to hygienic and sanitation policies set by Cresco Labs and the State.
  • Perform all assigned duties required to ensure a clean & safe workspace and production facility.
  • Maintain cleanliness of work area and equipment at all times.
  • Report all quality control issues during harvest to the supervisor immediately.
  • Maintain accurate records of product harvested and processed to ensure product identification and quality control.
  • Assist Cultivation Team lead with the creation of labels in accordance with the State and standards set by Cresco Labs.

Cresco Labs grows, processes, and retails cannabis products in eleven states, serving adult-use and medical markets. Its products come from its own cultivation and manufacturing facilities and are sold under a portfolio of trusted brands to ensure consistency. It differentiates itself through vertical integration—grower, processor, retailer—operating in high-demand, well-regulated markets to maintain quality and supply. Its goal is to expand market presence while upholding responsible practices, collaborating with governments, using eco-friendly packaging, and delivering value to shareholders and communities.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Ohio expansion reached seven dispensaries, strengthening local share in a high-priority market.
  • Texas conditional licensing opens entry into America's second-most populous state.
  • Needham Bank's $50 million revolver improves acquisition flexibility and reduces reliance on expensive private credit.

What critics are saying

  • Q1 2026 revenue fell to $151.3 million, while the company still lost $17.0 million.
  • Borrowings and interest payable reached $445.8 million, against only $32.3 million cash.
  • Federal Schedule III uncertainty and 280E exposure keep taxes, compliance, and financing highly unpredictable.

What makes Cresco Labs unique

  • Cresco combines cultivation, manufacturing, and Sunnyside retail under one vertically integrated model.
  • Its branded portfolio spans Cresco, High Supply, FloraCal, Good News, Wonder, and Remedi.
  • Management uses a consumer-packaged-goods approach, emphasizing national brands and education-first retail experiences.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cresco Labs who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Stock Options

Employee Discounts

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
AInvest
Apr 10th, 2026
Cresco Labs expands Ohio footprint with Sunnyside Bridgeport dispensary.

Cresco Labs expands Ohio footprint with Sunnyside Bridgeport dispensary. Friday, Apr 10, 2026 6:40 am ET 1min read Cresco Labs has opened Sunnyside Bridgeport, its seventh dispensary in Ohio and 73rd nationwide. The dispensary is located in downtown Bridgeport and offers a wide selection of cannabis products from Cresco Labs' brand portfolio. Customers can shop in-store or online for convenient pickup, with the store open daily from 9 a.m. to 9 p.m. Cresco Labs aims to normalize and professionalize the cannabis industry through its CPG approach to building national brands and a customer-focused retail experience. Cresco Labs Inc. has opened Sunnyside Bridgeport, its seventh dispensary in Ohio and 73rd nationwide, marking continued expansion in the U.S. cannabis market. Located in downtown Bridgeport at 435 Main Street, the dispensary is housed in a former bank building and is expected to contribute to local economic development through job creation and tax revenue. The facility will offer both recreational and medicinal cannabis products, sourced from Cresco Labs' brand portfolio, with in-store and online ordering options available. The dispensary is projected to employ approximately 12-15 full-time and 10-12 part-time workers, with competitive wages and benefits for full-time employees, including health insurance and stock investment opportunities. Bridgeport officials have emphasized that hiring will prioritize local residents, aligning with the company's commitment to community engagement. Revenue from the dispensary will generate local tax contributions, with 3.4% of gross sales allocated to Bridgeport, which could provide significant funding for public services. The strategic location near state borders enhances the dispensary's accessibility to neighboring states, supporting broader market reach. Cresco Labs continues to strengthen its position in the Ohio market, where it holds the top retail market share and third-largest branded product share. The company's expansion strategy reflects its mission to normalize and professionalize the cannabis industry through a consumer-focused retail model and national brand development. Ask Aime: What is the impact of Cresco Labs' expansion on the Ohio cannabis market? Aime insights. Which companies have consistent earnings growth and high profit margins? Which of Cathie Wood's stocks is she holding at a loss, that are worth me buying at the bottom? Which stocks are commonly held by Cathie Wood and Pelosi? Give me three stocks in an uptrend with cumulative gains not exceeding 20% in the last month?

The Associated Press
Apr 10th, 2026
Cresco Labs opens seventh Ohio cannabis dispensary in Bridgeport

Cresco Labs has opened its seventh Ohio dispensary, Sunnyside Bridgeport, located at 435 Main Street in Bridgeport. The new location marks the company's 73rd dispensary nationwide. The store is situated in downtown Bridgeport near the Ohio River, close to I-70 and U.S. Route 40. It offers cannabis products from Cresco Labs' brand portfolio, including Cresco, Supply, Good News, Mindy's and Wonder, along with accessories. Customers aged 21 and older can shop in-store or order online for pickup. The dispensary operates daily from 9 a.m. to 9 p.m. CEO Charlie Bachtell said the opening brings the company's "education-first approach" to more consumers across Belmont County and the Ohio Valley region.

Yahoo Finance
Apr 6th, 2026
Cresco Labs price target trimmed to $1.64 as analysts flag execution risk despite upside

Cresco Labs faces a trimmed price target of CA$2.25 from CA$2.50 by Canaccord, which maintains a Speculative Buy rating despite elevated execution risk. The updated fair value estimate stands at CA$2.44, suggesting modest upside but reflecting cautious analyst sentiment on the company's near-term progress. The cannabis operator recently secured conditional approval for a vertically integrated medical cannabis licence in Texas, one of the largest potential markets in the US. Cresco also expanded its retail footprint through a partnership bringing Bloom's vape products into Pennsylvania's Sunnyside dispensaries. However, labour tensions emerged as workers at a Pennsylvania location voted to authorise a strike before reaching a new contract with higher wages and improved benefits after a 20-day work stoppage.

Business Wire
Apr 2nd, 2026
Cresco Labs wins Texas medical cannabis licence for cultivation and dispensary operations

Cresco Labs has been conditionally awarded a vertically integrated Texas Compassionate Use Program licence, allowing the company to cultivate, process and dispense medical cannabis. The licence enables capital-efficient entry into Texas, America's second-most populous state with nearly 30 million residents. The merit-based award reflects Cresco Labs' regulatory expertise and approach to local engagement. CEO Charlie Bachtell said the company's track record in medical markets positions it to build robust programmes prioritising patients and communities. The licence advances Cresco Labs' state-by-state growth strategy, securing access to one of the largest patient populations in the US. Texas continues to see legislative efforts to improve patient access and broaden qualifying conditions for medical cannabis use.

Yahoo Finance
Mar 5th, 2026
Cresco Labs posts $162M Q4 revenue and $40M EBITDA despite 6% wholesale decline

Cresco Labs reported Q4 2025 revenue of $162 million and full-year revenue of $656 million. The cannabis company achieved adjusted EBITDA of $40 million in the quarter and $157 million for the year, with operating cash flow of $27 million in Q4. Adjusted gross margin improved to 52.2% in Q4, up from 48.8% in Q3. The company strengthened its balance sheet by refinancing debt with maturities extending to 2030 and exited the California market to focus on higher-return regions. Cresco maintained the top branded market share in Illinois, Pennsylvania and Massachusetts. However, wholesale revenue declined approximately 6% quarter-over-quarter. The company expects a high single-digit sequential revenue decline in Q1 2026 due to Michigan's excise tax changes and the California exit.

INACTIVE